Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 07 entities : Eli lilly and company save search
FDA Extends Supplemental NDA Review Period for Lilly and Incyte’s Atopic Derm...
Published: 2021-04-07 (Crawled : 18:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
fda
FDA Extends Supplemental NDA Review Period for Lilly and Incyte’s Atopic Dermatitis Drug
Published: 2021-04-07 (Crawled : 18:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
fda dermatitis drug atopic dermatitis
Cluster Headache Market to Expand at 5.30% CAGR, Growing Demand Calls for Better Treatment to Patients, Anticipates DelveInsight
Published: 2021-04-07 (Crawled : 17:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
treatment growing
DTx Pharma to Participate in the 2021 Needham Virtual Healthcare Conference
Published: 2021-04-07 (Crawled : 14:15) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
conference needham virtual healthcare conference pharma
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-04-07 (Crawled : 13:50) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.06%
H: 0.58%
C: -0.33%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.05%
H: 0.85%
C: 0.08%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.14%
H: 0.57%
C: -0.3%
YMAB | $15.15 1.0% 0.99% 470K
|
Health Technology
|
| O: -1.89%
H: 2.21%
C: -2.28%
VSTM | $9.86 -3.62% -3.75% 150K
|
Health Technology
|
| O: -1.77%
H: 5.04%
C: -0.36%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.74%
H: 0.22%
C: -0.38%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: 0.75%
H: 1.63%
C: -3.42%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.07%
H: 1.66%
C: 0.58%
KPTI | $1.16 -9.38% -10.34% 1.4M
|
Health Technology
|
| O: 0.0%
H: 1.86%
C: -2.2%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: -2.55%
ILMN | $117.43 0.63% 0.63% 1.4M
|
Health Technology
|
| O: -0.65%
H: 0.6%
C: -2.81%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: 0.47%
H: 1.45%
C: -0.09%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 0.58%
H: 1.38%
C: -2.99%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: -0.72%
H: 1.61%
C: -3.94%
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.83%
H: 0.33%
C: -3.34%
BGNE | $129.51 -1.86% -1.89% 300K
|
Health Technology
|
| O: -0.53%
H: 0.15%
C: -1.82%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 0.0%
H: 0.71%
C: -3.81%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.37%
H: 0.83%
C: -0.02%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.46%
H: 1.19%
C: -0.49%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: -1.13%
H: 0.99%
C: -1.05%
cancer approval
Rigel Announces Closing of Strategic Collaboration with Lilly
Published: 2021-04-07 (Crawled : 12:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
RIGL | $1.07 1.91% 1.87% 810K
|
Health Technology
|
| O: 0.75%
H: 1.63%
C: -3.42%
collaboration
Global Psoriasis Drugs Market to Reach $53,210.6 Million by 2030, says P&S Intelligence
Published: 2021-04-07 (Crawled : 08:00) - prnewswire.com
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.02%
H: 0.34%
C: -0.09%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.45%
C: 0.04%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.58%
H: 0.28%
C: -0.47%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.05%
H: 0.15%
C: -0.32%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.05%
H: 0.85%
C: 0.08%
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.1%
H: 1.33%
C: 1.09%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.14%
H: 0.57%
C: -0.3%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.37%
H: 0.83%
C: -0.02%
drug psoriasis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.